Compound Summary
Compound Name: | maltose |
Compound CID: | 6255 |
Synonyms: | maltose beta-maltose D-Maltose 69-79-4 133-99-3 More... |
Iupac Name: | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol |
InChI: | InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11-,12-/m1/s1 |
InChIKey: | GUBGYTABKSRVRQ-QUYVBRFLSA-N |
Canonical Smiles: | C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O |
Isomeric Smiles: | C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O |
Molecular Weight: | 342.3 |
Molecular Formula: | C12H22O11 |
Molecular Weight: | 342.3 |
Molecular Formula: | C12H22O11 |
Hydrogen Bond Donor Count: | 8 |
Hydrogen Bond Acceptor Count: | 11 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 23 |
Complexity: | 382 |
maltose | maltose |
---|---|
maltose |
beta-maltose |
D-Maltose |
69-79-4 |
133-99-3 |
Maltobiose |
D-(+)-Maltose |
4-O-alpha-D-glucopyranosyl-beta-D-glucopyranose |
UNII-R4B6462NGR |
Cextromaltose |
Finetose |
Maltodiose |
Sunmalt |
Malt sugar |
Finetose F |
Sunmalt S |
cellobiose |
R4B6462NGR |
INSULIN, (ARG-INSULIN) |
Maltose, pure |
CHEBI:18147 |
BETA-D-GLUCOPYRANOSYL(1-4)-D-GLUCOPYRANOSE |
beta-D-Cellobiose |
beta-D-glucopyranose, 4-O-alpha-D-glucopyranosyl- |
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yloxyoxane-3,4,5-triol |
4-(alpha-D-Glucosido)-D-glucose |
4-(alpha-D-Glucopyranosido)-alpha-glucopyranose |
4-O-alpha-D-Glucopyranosyl-D-glucose |
D-Glucose, 4-O-alpha-D-glucopyranosyl- |
120022-04-0 |
B-D-GLUCOPYRANOSE, 4-O-A-D-GLUCOPYRANOSYL- |
alpha-D-glucopyranosyl-(1->4)-beta-D-glucopyranose |
AI3-09089 |
Maltose HH |
Maltose HHH |
Advantose 100 |
beta-D-Maltose |
Maltose, beta- |
(2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal |
Maltose beta-anomer |
4-O-a-D-Glucopyranosyl-D-glucose |
1wdr |
N9S |
Glca1-4Glcb |
Glcalpha1-4Glcbeta |
Maltose (8CI) |
SUNMALT-S |
2f5t |
SCHEMBL15064 |
CHEMBL1908365 |
DTXSID1023233 |
HMS3264C14 |
Pharmakon1600-01301024 |
ZINC4095762 |
NSC760396 |
alpha-D-Glcp-(1->4)-beta-D-Glcp |
CCG-231520 |
NSC-760396 |
NCGC00389762-01 |
BS-10031 |
ST012003 |
C01971 |
D70315 |
4-O-(alpha-D-Glucopyranosyl)-beta-D-glucopyranose |
alpha-D-glucopyranose-(1->4)-beta-D-glucopyranose |
857A38D2-86D7-41F1-BC3C-DADBC19CF9DC |
D-Glucose, 4-O-alpha-D-glucopyranosyl- (6CI,9CI) |
Q26914030 |
WURCS=2.0/2,2,1/a2122h-1b_1-5a2122h-1a_1-5/1-2/a4-b1 |
(2R,3S,4S,5R,6R)-2-methylol-6-(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-methylol-tetrahydropyran-3-yloxy-tetrahydropyran-3,4,5-triol |
(5S,2R,3R,4R,6R)-5-(4S,5S,2R,3R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)(2H-3,4 ,5,6-tetrahydropyran-2-yloxy)-6-(hydroxymethyl)-2H-3,4,5,6-tetrahydropyran-2, 3,4-triol |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 5.000000000000000 | mM | 8.000000000000000 | 5.000000000000000 | S | N2 | 33683565 | Active | |||||
Caenorhabditis elegans | 5.000000000000000 | mM | 26.900000000000000 | 29.100000000000000 | 8.000000000000000 | 39.000000000000000 | 41.000000000000000 | 5.000000000000000 | S | 20477758 | Active |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 8.000000000000000 | 5.000000000000000 | 2 | 2 |